Arcellx (ACLX) Other Non-Current Assets (2021 - 2025)

Arcellx's quarterly Other Non-Current Assets came in at $3.0 million in Q4 2025, up 179.29% year-on-year from $1.1 million in Q4 2024, and up 814.29% quarter-over-quarter from $329000.0 in Q3 2025.

Arcellx has reported Other Non-Current Assets for 5 years, with the latest figure at $3.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 179.29% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2025 stood at $3.0 million (up 179.29% YoY), and the FY2025 full-year result was $3.0 million, up 179.29% from the prior year.
  • Other Non-Current Assets for Q4 2025 stood at $3.0 million, up from $329000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $9.4 million in Q4 2023, with the low at $199000.0 in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $2.6 million, with a median of $2.5 million recorded in 2022.
  • Year-over-year, Other Non-Current Assets soared 1156.78% in 2023 and sank 88.49% in 2024.
  • Tracing ACLX's Other Non-Current Assets over 5 years: stood at $3.2 million in 2021, then slipped by 21.15% to $2.5 million in 2022, then surged by 274.09% to $9.4 million in 2023, then slumped by 88.49% to $1.1 million in 2024, then soared by 179.29% to $3.0 million in 2025.
  • The last three Other Non-Current Assets figures came in at $3.0 million (Q4 2025), $329000.0 (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 3.01 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.01 Mn
Sep 30, 2025 329,000.00
Jun 30, 2025 2.42 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 1.08 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.22 Mn
Mar 31, 2024 2.42 Mn
Dec 31, 2023 9.36 Mn
Sep 30, 2023 4.93 Mn
Jun 30, 2023 2.50 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 199,000.00
Dec 31, 2021 3.17 Mn